1. Home
  2. GBIO vs PWOD Comparison

GBIO vs PWOD Comparison

Compare GBIO & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • PWOD
  • Stock Information
  • Founded
  • GBIO 2016
  • PWOD 1934
  • Country
  • GBIO United States
  • PWOD United States
  • Employees
  • GBIO N/A
  • PWOD N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • PWOD Major Banks
  • Sector
  • GBIO Health Care
  • PWOD Finance
  • Exchange
  • GBIO Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • GBIO 166.2M
  • PWOD 173.1M
  • IPO Year
  • GBIO 2020
  • PWOD N/A
  • Fundamental
  • Price
  • GBIO $2.59
  • PWOD $22.44
  • Analyst Decision
  • GBIO Buy
  • PWOD
  • Analyst Count
  • GBIO 4
  • PWOD 0
  • Target Price
  • GBIO $7.50
  • PWOD N/A
  • AVG Volume (30 Days)
  • GBIO 74.2K
  • PWOD 11.5K
  • Earning Date
  • GBIO 11-07-2024
  • PWOD 10-23-2024
  • Dividend Yield
  • GBIO N/A
  • PWOD 5.82%
  • EPS Growth
  • GBIO N/A
  • PWOD N/A
  • EPS
  • GBIO N/A
  • PWOD 2.31
  • Revenue
  • GBIO $13,174,000.00
  • PWOD $64,822,000.00
  • Revenue This Year
  • GBIO $99.36
  • PWOD N/A
  • Revenue Next Year
  • GBIO N/A
  • PWOD N/A
  • P/E Ratio
  • GBIO N/A
  • PWOD $9.52
  • Revenue Growth
  • GBIO 1397.05
  • PWOD N/A
  • 52 Week Low
  • GBIO $0.86
  • PWOD $17.01
  • 52 Week High
  • GBIO $4.65
  • PWOD $24.10
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 51.42
  • PWOD 55.64
  • Support Level
  • GBIO $2.41
  • PWOD $20.18
  • Resistance Level
  • GBIO $2.63
  • PWOD $21.73
  • Average True Range (ATR)
  • GBIO 0.22
  • PWOD 0.74
  • MACD
  • GBIO 0.03
  • PWOD 0.05
  • Stochastic Oscillator
  • GBIO 56.79
  • PWOD 64.20

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: